Lian B - Search Results

1

Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma.

Yan X, Sheng X, Chi Z, Si L, Cui C, Kong Y, Tang B, Mao L, Wang X, Lian B, Li S, Bai X, Zhou L, Dai J, Yao H, Guo J. Yan X, et al. Among authors: lian b. J Clin Oncol. 2021 Mar 10;39(8):881-889. doi: 10.1200/JCO.20.00902. Epub 2021 Jan 14. J Clin Oncol. 2021. PMID: 33444116 Clinical Trial.

2

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients.

Lian B, Cui CL, Zhou L, Song X, Zhang XS, Wu D, Si L, Chi ZH, Sheng XN, Mao LL, Wang X, Tang BX, Yan XQ, Kong Y, Dai J, Li SM, Bai X, Zheng N, Balch CM, Guo J. Lian B, et al. Ann Oncol. 2017 Apr 1;28(4):868-873. doi: 10.1093/annonc/mdw694. Ann Oncol. 2017. PMID: 28039178 Free article.

3

Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial.

Lian B, Si L, Chi ZH, Sheng XN, Kong Y, Wang X, Tian H, Li K, Mao LL, Bai X, Tang BX, Yan XQ, Li SM, Zhou L, Dai J, Tang XW, Ran FW, Yao S, Guo J, Cui CL. Lian B, et al. Ann Oncol. 2022 Oct;33(10):1061-1070. doi: 10.1016/j.annonc.2022.07.002. Epub 2022 Jul 14. Ann Oncol. 2022. PMID: 35842199 Free article. Clinical Trial.

4

A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.

Cui C, Mao L, Chi Z, Si L, Sheng X, Kong Y, Li S, Lian B, Gu K, Tao M, Song X, Lin T, Ren X, Qin S, Guo J. Cui C, et al. Among authors: lian b. Mol Ther. 2013 Jul;21(7):1456-63. doi: 10.1038/mt.2013.79. Epub 2013 May 14. Mol Ther. 2013. PMID: 23670576 Free PMC article. Clinical Trial.

5

Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.

Lian B, Si L, Cui C, Chi Z, Sheng X, Mao L, Li S, Kong Y, Tang B, Guo J. Lian B, et al. Clin Cancer Res. 2013 Aug 15;19(16):4488-98. doi: 10.1158/1078-0432.CCR-13-0739. Epub 2013 Jul 5. Clin Cancer Res. 2013. PMID: 23833309 Clinical Trial.

6

Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.

Sheng X, Li S, Chi Z, Si L, Cui C, Mao L, Lian B, Tang B, Wang X, Yan X, Kong Y, Dai J, Guo J. Sheng X, et al. Among authors: lian b. Br J Ophthalmol. 2015 Jul;99(7):990-6. doi: 10.1136/bjophthalmol-2014-305730. Epub 2015 Jan 16. Br J Ophthalmol. 2015. PMID: 25595173

7

Adjuvant therapy of mucosal melanoma.

Lian B, Guo J. Lian B, et al. Chin Clin Oncol. 2014 Sep;3(3):33. doi: 10.3978/j.issn.2304-3865.2014.08.01. Chin Clin Oncol. 2014. PMID: 25841459 Free article.

8

Checkpoint inhibitors in treatment of metastatic mucosal melanoma.

Lian B, Guo J. Lian B, et al. Chin Clin Oncol. 2014 Sep;3(3):37. doi: 10.3978/j.issn.2304-3865.2014.07.05. Chin Clin Oncol. 2014. PMID: 25841463 Free article.

9

[A pilot study of sunitinib as first-line therapy for metastatic renal cell carcinoma on a 2 weeks on/1 week off intermittent dosing schedule].

Cui C, Li S, Chi Z, Si L, Sheng X, Mao L, Lian B, Wang X, Tang B, Guo J. Cui C, et al. Among authors: lian b. Zhonghua Zhong Liu Za Zhi. 2015 May;37(5):375-8. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26463030 Chinese.

10

GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.

Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, Chi Z, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Dai J, Guo J. Sheng X, et al. Among authors: lian b. Eur J Cancer. 2016 Sep;65:156-63. doi: 10.1016/j.ejca.2016.06.019. Epub 2016 Aug 4. Eur J Cancer. 2016. PMID: 27498141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

576 results

Search Page

Filters